Amended Statement of Changes in Beneficial Ownership (4/a)
August 14 2014 - 12:58PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
TOMAS MIKE
|
2. Issuer Name
and
Ticker or Trading Symbol
BIOHEART, INC.
[
BHRT.OB
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
CEO & President
|
(Last)
(First)
(Middle)
13794 NW 4TH STREET, SUITE 212
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
2/24/2014
|
(Street)
SUNRISE, FL 33325
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
8/13/2014
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
|
|
|
|
|
|
|
6578947
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Stock option (right to buy)
|
$0.0169
|
|
|
|
|
|
|
9/18/2010
|
6/18/2020
|
Common Stock
|
500000
|
|
500000
|
D
|
|
Stock option (right to buy)
|
$0.0169
|
|
|
|
|
|
|
8/12/2011
|
8/12/2021
|
Common Stock
|
500000
(1)
|
|
1000000
|
D
|
|
Stock option (right to buy)
|
$0.0169
|
|
|
|
|
|
|
1/16/2012
|
1/16/2022
|
Common Stock
|
500000
(2)
|
|
1500000
|
D
|
|
Stock option (right to buy)
|
$0.0169
|
|
|
|
|
|
|
8/6/2005
|
8/6/2022
|
Common Stock
|
2000000
(3)
|
|
3500000
|
D
|
|
Stock option (right to buy)
|
$0.0158
|
|
|
|
|
|
|
8/1/2013
|
8/1/2023
|
Common Stock
|
10000000
(4)
|
|
13500000
|
D
|
|
Stock option (right to buy)
|
$0.0165
|
|
|
|
|
|
|
9/1/2013
|
9/1/2023
|
Common Stock
|
400000
|
|
13900000
|
D
|
|
Stock option (right to buy)
|
$0.019
|
|
|
|
|
|
|
2/24/2014
|
2/24/2024
|
Common Stock
|
10000000
(5)
|
|
23900000
|
D
|
|
Stock option (right to buy)
|
$0.019
|
|
|
|
|
|
|
2/24/2014
|
2/24/2024
|
Common Stock
|
800000
|
|
24700000
|
D
|
|
Stock option (right to buy)
|
$0.0272
|
|
|
|
|
|
|
5/12/2014
|
5/12/2024
|
Common Stock
|
4298487
(6)
|
|
28998487
|
D
|
|
Stock option (right to buy)
|
$0.0269
|
8/1/2014
|
8/1/2014
|
A
|
|
10000000
(7)
|
|
8/1/2014
|
8/1/2024
|
Common Stock
|
10000000
(7)
|
$0
(8)
|
38998487
|
D
|
|
Explanation of Responses:
|
(
1)
|
375,000 have vested, remainder vest on 08/12/2015.
|
(
2)
|
375,000 have vested, remainder vest on 08/12/2015.
|
(
3)
|
Vest on 8/6/2016.
|
(
4)
|
2,500,000 have vested, remainder vest in equal installments on 8/1/2015, 8/1/2016 and 8/1/2017.
|
(
5)
|
2,500,000 have vested, remainder vest in equal installments on 9/1/2015, 9/1/2016 and 9/1/2017.
|
(
6)
|
Vest in equal installments on 5/12/2015, 5/12/2016, 5/12/2017, and 5/12/2018.
|
(
7)
|
2,500,000 have vested, remainder vest in equal installments on 8/1/2015, 8/1/2016 and 8/1/2017.
|
(
8)
|
Bonus Grant
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
TOMAS MIKE
13794 NW 4TH STREET
SUITE 212
SUNRISE, FL 33325
|
X
|
|
CEO & President
|
|
Signatures
|
/s/ Mike Tomas
|
|
8/14/2014
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
US Stem Cell (CE) (USOTC:USRM)
Historical Stock Chart
From Apr 2024 to May 2024
US Stem Cell (CE) (USOTC:USRM)
Historical Stock Chart
From May 2023 to May 2024